CDKN2B-AS1 and atherosclerosis: In this study, serum ANRIL levels decreased significantly one year after SG and exhibited a strong correlation with CIMT (MD: 0.04 mm per fold change, p < 0.001), supporting its utility as a surrogate marker of subclinical atherosclerosis.